AgroFresh Announces CFO Change; Names Graham Miao as New CFO
16:30 ET
"We are excited to have someone of Graham's caliber, with his education and extensive finance experience, join AgroFresh," said AgroFresh CEO Jordi Ferre. "His proven record and expertise in leading global financial and business operations, managing M&A activity, executing complex transactions in the debt and equity markets, as well as his demonstrated ability to build high-performing teams will, we believe, add immediate value to the company."
"We want to thank Kathy for her financial leadership as AgroFresh has matured as a public company, including successfully completing and integrating our first acquisition," Ferre added. "We wish her the best as she pursues new opportunities."
While at Pernix Therapeutics, Miao delivered profitability improvements over several quarters and completed a $180 million debt restructuring, providing the financial flexibility to pursue growth. Prior to joining Pernix, he served as the executive vice president and CFO of Interpace Diagnostics, Inc. (formerly known as PDI, Inc., or PDI), a NASDAQ listed healthcare commercialization company. Miao's career has included a broad range of senior financial positions in other life sciences companies, as well as earlier roles at Dun & Bradstreet and J.P. Morgan & Co.
Miao holds a bachelor's degree in biology from Fudan University in Shanghai, China, a master's degree in molecular biology and genetics from Arizona State University and an MBA and Ph.D. in biological sciences from Columbia University.
SOURCE AgroFresh Solutions, Inc.